• Citer

Comparison of mycophenolate mofetil and azathioprine for prevention of bronchiolitis obliterans syndrome in de novo lung transplant recipients.

par McNeil, Keith;Glanville, Allan R.;Wahlers, Thorsten;Knoop, Christiane ;Speich, Rudolf;Mamelok, Richard D;Maurer, Joerg;Ives, Jane;Corris, Paul A.
Référence Transplantation, 81, 7, page (998-1003)
Publication Publié, 2006-04

Article révisé par les pairs

• Détails
• Contenu

Résumé :

There are no data on the effects of mycophenolate mofetil (MMF) on the incidence of bronchiolitis obliterans syndrome (BOS) in lung-transplant patients. This study attempted to determine whether MMF reduces the incidence of BOS in de novo lung transplant recipients compared with azathioprine (AZA).